Genomic DNA methylation profiling indicates immune response following thermal ablation treatment for HBV‑associated hepatocellular carcinoma-Reference-Cited by-同舟云学术

Genomic DNA methylation profiling indicates immune response following thermal ablation treatment for HBV‑associated hepatocellular carcinoma

Published:2020-05-18 Issue:1 Volume:20 Page:677-684
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Zhao Yanan¹,Li Kang¹,Sun Jianping¹,He Ning²,Zhao Peng²,Zang Chaoran¹,Yang Xiaozhen²,Hu Caixia²,Long Jiang²,Zhang Honghai²,Wang Qi¹,Zhao Yan³,Zhang Yonghong¹

Affiliation:

1. Research Center for Biomedical Resources, You'an Hospital, Capital Medical University, Beijing 100069, P.R. China

2. Interventional Therapy Center for Oncology, Beijing You'an Hospital, Capital Medical University, Beijing 100069, P.R. China

3. Clinical Detection Center, Beijing You'an Hospital, Capital Medical University, Beijing 100069, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination Therapy of Immune Checkpoint Inhibitors with Locoregional Therapy for Hepatocellular Carcinoma;Cancers;2023-10-20

2. Interim efficacy and safety of PD-1 inhibitors in preventing recurrence of hepatocellular carcinoma after interventional therapy;Frontiers in Immunology;2022-10-28

3. Combined DNA Methylation and Transcriptomic Assessments to Determine a Prognostic Model for PD-1-Negative Hepatocellular Carcinoma;Frontiers in Cell and Developmental Biology;2021-08-11

4. Combined DNA Methylation and Transcriptomic Assessments to Determine a Prognostic Model for PD-1-Negative Hepatocellular Carcinoma;FRONT CELL DEV BIOL;2021